AN INTERNATIONAL, MULTICENTRE, OPEN-LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF TWO DIFFERENT VACCINATION REGIMENS OF IMMUNOTHERAPY WITH ALLOGENEIC DENDRITIC CELLS, DCP-001, IN PATIENTS WITH ACUTE MYELOID LEUKAEMIA THAT ARE IN REMISSION WITH PERSISTENT MRD. - ADVANCE II
100 Clinical Results associated with DCPrime BV
0 Patents (Medical) associated with DCPrime BV
100 Deals associated with DCPrime BV
100 Translational Medicine associated with DCPrime BV